CME Group Inc. $CME Position Boosted by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D boosted its holdings in CME Group Inc. (NASDAQ:CME) by 2.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 123,977 shares of the financial services provider’s stock after acquiring an additional 3,064 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in CME Group were worth $33,497,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of CME Group during the second quarter valued at $1,571,447,000. Mawer Investment Management Ltd. grew its position in CME Group by 107.2% in the 3rd quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider’s stock valued at $406,029,000 after buying an additional 777,571 shares in the last quarter. Viking Global Investors LP acquired a new position in CME Group during the 2nd quarter valued at about $164,648,000. Vanguard Group Inc. increased its stake in CME Group by 1.5% during the 2nd quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock valued at $9,695,313,000 after buying an additional 532,549 shares during the period. Finally, Magellan Asset Management Ltd raised its position in shares of CME Group by 131,625.5% during the 2nd quarter. Magellan Asset Management Ltd now owns 486,067 shares of the financial services provider’s stock worth $133,970,000 after buying an additional 485,698 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director directly owned 2,699 shares of the company’s stock, valued at $809,700. The trade was a 21.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William R. Shepard bought 251 shares of the firm’s stock in a transaction dated Tuesday, December 30th. The stock was acquired at an average cost of $278.37 per share, with a total value of $69,870.87. Following the transaction, the director owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CME has been the subject of several recent analyst reports. UBS Group reiterated a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a report on Friday, February 6th. TD Cowen upped their target price on CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Rothschild & Co Redburn lifted their price target on CME Group from $300.00 to $333.00 and gave the company a “neutral” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft boosted their price objective on CME Group from $312.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, February 5th. Finally, Barclays raised their target price on CME Group from $304.00 to $312.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $299.53.

CME Group Price Performance

Shares of NASDAQ:CME opened at $303.07 on Monday. The company has a market capitalization of $109.29 billion, a PE ratio of 27.16, a price-to-earnings-growth ratio of 3.29 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock has a fifty day moving average of $279.82 and a 200-day moving average of $273.97. CME Group Inc. has a one year low of $244.43 and a one year high of $309.35.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the firm earned $2.52 earnings per share. CME Group’s revenue for the quarter was up 8.1% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be paid a dividend of $1.30 per share. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is currently 44.80%.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.